BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32357942)

  • 1. Diagnostic performance of standard breast MR imaging compared to dedicated axillary MR imaging in the evaluation of axillary lymph node.
    Ha SM; Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
    BMC Med Imaging; 2020 May; 20(1):45. PubMed ID: 32357942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of standard breast MRI compared to dedicated axillary MRI for assessment of node-negative and node-positive breast cancer.
    Samiei S; Smidt ML; Vanwetswinkel S; Engelen SME; Schipper RJ; Lobbes MBI; van Nijnatten TJA
    Eur Radiol; 2020 Aug; 30(8):4212-4222. PubMed ID: 32221685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Performance of Dedicated Axillary T2- and Diffusion-weighted MR Imaging for Nodal Staging in Breast Cancer.
    Schipper RJ; Paiman ML; Beets-Tan RG; Nelemans PJ; de Vries B; Heuts EM; van de Vijver KK; Keymeulen KB; Brans B; Smidt ML; Lobbes MB
    Radiology; 2015 May; 275(2):345-55. PubMed ID: 25513854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients.
    van Nijnatten TJA; Ploumen EH; Schipper RJ; Goorts B; Andriessen EH; Vanwetswinkel S; Schavemaker M; Nelemans P; de Vries B; Beets-Tan RGH; Smidt ML; Lobbes MBI
    Eur J Radiol; 2016 Dec; 85(12):2288-2294. PubMed ID: 27842679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of axillary lymph nodes in patients with breast cancer with diffusion-weighted MR imaging in combination with routine and dynamic contrast MR imaging.
    Razek AA; Lattif MA; Denewer A; Farouk O; Nada N
    Breast Cancer; 2016 May; 23(3):525-32. PubMed ID: 25763535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of axillary ultrasound and standard breast MRI for differentiation between limited and advanced axillary nodal disease in clinically node-positive breast cancer patients.
    Samiei S; van Nijnatten TJA; van Beek HC; Polak MPJ; Maaskant-Braat AJG; Heuts EM; van Kuijk SMJ; Schipper RJ; Lobbes MBI; Smidt ML
    Sci Rep; 2019 Nov; 9(1):17476. PubMed ID: 31767929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
    Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
    Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of preoperative breast magnetic resonance imaging with a dedicated axillary sequence for the detection of axillary lymph node metastasis in patients with early ductal breast cancer.
    Ahn HS; Jang M; Kim SM; La Yun B; Lee SH
    Radiol Med; 2019 Dec; 124(12):1220-1228. PubMed ID: 31422573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
    Memarsadeghi M; Riedl CC; Kaneider A; Galid A; Rudas M; Matzek W; Helbich TH
    Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid
    de Mooij CM; Samiei S; Mitea C; Lobbes MBI; Kooreman LFS; Heuts EM; Beets-Tan RGH; van Nijnatten TJA; Smidt ML
    Clin Radiol; 2022 Oct; 77(10):e732-e740. PubMed ID: 35850866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study.
    van Nijnatten TJA; Goorts B; Vöö S; de Boer M; Kooreman LFS; Heuts EM; Wildberger JE; Mottaghy FM; Lobbes MBI; Smidt ML
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):179-186. PubMed ID: 28905091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of axillary response by monitoring with ultrasound and MRI during and after neoadjuvant chemotherapy in breast cancer patients.
    Eun NL; Son EJ; Gweon HM; Kim JA; Youk JH
    Eur Radiol; 2020 Mar; 30(3):1460-1469. PubMed ID: 31802216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted MR imaging increases diagnostic accuracy of breast MR imaging for predicting axillary metastases in breast cancer patients.
    Guvenc I; Whitman GJ; Liu P; Yalniz C; Ma J; Dogan BE
    Breast J; 2019 Jan; 25(1):47-55. PubMed ID: 30444286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Added Value of MRI for Invasive Breast Cancer including the Entire Axilla for Evaluation of High-Level or Advanced Axillary Lymph Node Metastasis in the Post-ACOSOG Z0011 Trial Era.
    Byon JH; Park YV; Yoon JH; Moon HJ; Kim EK; Kim MJ; You JK
    Radiology; 2021 Jul; 300(1):46-54. PubMed ID: 33904772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating axillary lymph node metastasis in invasive breast cancer patients: A comparison of radiomic signatures from multiparametric breast MR sequences.
    Chai R; Ma H; Xu M; Arefan D; Cui X; Liu Y; Zhang L; Wu S; Xu K
    J Magn Reson Imaging; 2019 Oct; 50(4):1125-1132. PubMed ID: 30848041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study.
    Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG
    Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging features for predicting axillary lymph node metastasis in patients with breast cancer.
    Zhao M; Wu Q; Guo L; Zhou L; Fu K
    Eur J Radiol; 2020 Aug; 129():109093. PubMed ID: 32512504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer.
    Kim R; Chang JM; Lee HB; Lee SH; Kim SY; Kim ES; Cho N; Moon WK
    Radiology; 2019 Oct; 293(1):49-57. PubMed ID: 31407967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does axillary lymph node size predict better metastatic involvement than apparent diffusion coefficient (ADC) value in women with newly diagnosed breast cancer?
    Ramírez-Galván YA; Cardona-Huerta S; Elizondo-Riojas G; Álvarez-Villalobos NA; Campos-Coy MA; Ferrara-Chapa CM
    Acta Radiol; 2020 Nov; 61(11):1494-1504. PubMed ID: 32064890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between the contrast-enhanced ultrasound image features and axillary lymph node metastasis of primary breast cancer and its diagnostic value.
    Xu H; Xu GL; Li XD; Su QH; Dong CZ
    Clin Transl Oncol; 2021 Jan; 23(1):155-163. PubMed ID: 32488804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.